NanoViricides
NNVC
#10108
Rank
โ‚น2.10 B
Marketcap
โ‚น117.24
Share price
4.88%
Change (1 day)
-6.59%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น52.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น55.44. In 2024 the company made an earnings per share (EPS) of -โ‚น63.62 an increase over its 2023 EPS that were of -โ‚น67.25.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น52.14-18.04%
2024-โ‚น63.62-5.41%
2023-โ‚น67.255.71%
2022-โ‚น63.62-13.58%
2021-โ‚น73.62-66.11%
2020-โ‚น217.211.7%
2019-โ‚น213.58-10.98%
2018-โ‚น239.93-22.35%
2017-โ‚น309.00-10.53%
2016-โ‚น345.36375%
2015-โ‚น72.71-85.19%
2014-โ‚น490.7742.11%
2013-โ‚น345.3626.67%
2012-โ‚น272.65-6.25%
2011-โ‚น290.8214.28%
2010-โ‚น254.47100%
2009-โ‚น127.24-0%
2008-โ‚น127.24-33.33%
2007-โ‚น190.85-0%
2006-โ‚น190.854445.07%
2005-โ‚น4.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น4.54-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น192.67-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น592.56-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น269.92-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น690.15-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น326.81-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK